华宝医药生物混合C
(019029)权益主动型公募混合型
各季度资产配置
| 季报日期 | 净资总值(亿元) | 净资净值(亿元) | 股票 | 债券 | 现金 | 其他 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 市值(亿元) | 占净值比例(%) | 占总值比例(%) | 市值(亿元) | 占净值比例(%) | 占总值比例(%) | 市值(亿元) | 占净值比例(%) | 占总值比例(%) | 市值(亿元) | 占净值比例(%) | 占总值比例(%) | |||
| 2026-03-31 | 6.70 | 6.18 | 5.52 | 80.95% | 82.42% | 0.00 | 0.00% | 0.00% | 1.12 | 18.14% | 16.74% | 0.06 | 0.91% | 0.84% |
| 2025-12-31 | 5.40 | 5.36 | 4.62 | 85.46% | 85.57% | 0.00 | 0.00% | 0.00% | 0.71 | 13.30% | 13.20% | 0.07 | 1.24% | 1.23% |
| 2025-09-30 | 6.63 | 6.29 | 5.76 | 86.12% | 86.84% | 0.00 | 0.00% | 0.00% | 0.85 | 13.50% | 12.80% | 0.02 | 0.38% | 0.36% |
| 2025-06-30 | 5.52 | 5.21 | 4.65 | 83.31% | 84.23% | 0.00 | 0.00% | 0.00% | 0.85 | 16.31% | 15.41% | 0.02 | 0.38% | 0.36% |
| 2025-03-31 | 6.10 | 6.06 | 5.51 | 90.28% | 90.35% | 0.00 | 0.00% | 0.00% | 0.58 | 9.50% | 9.43% | 0.01 | 0.22% | 0.22% |
| 2024-12-31 | 5.50 | 5.44 | 4.62 | 83.80% | 83.96% | 0.00 | 0.00% | 0.00% | 0.65 | 11.97% | 11.85% | 0.23 | 4.23% | 4.19% |
| 2024-09-30 | 8.79 | 8.71 | 8.18 | 93.06% | 93.12% | 0.00 | 0.00% | 0.00% | 0.56 | 6.48% | 6.42% | 0.04 | 0.46% | 0.46% |
| 2024-06-30 | 8.61 | 8.55 | 7.56 | 87.72% | 87.80% | 0.00 | 0.00% | 0.00% | 1.03 | 12.08% | 12.00% | 0.02 | 0.20% | 0.20% |
| 2024-03-31 | 11.96 | 11.58 | 10.60 | 88.27% | 88.64% | 0.00 | 0.00% | 0.00% | 1.35 | 11.67% | 11.30% | 0.01 | 0.06% | 0.06% |
| 2023-12-31 | 13.49 | 13.43 | 12.25 | 90.71% | 90.76% | 0.00 | 0.00% | 0.00% | 1.16 | 8.66% | 8.61% | 0.08 | 0.63% | 0.63% |
| 2023-09-30 | 8.04 | 7.68 | 6.18 | 80.48% | 76.86% | 0.00 | 0.00% | 0.00% | 0.74 | 9.68% | 9.25% | 1.12 | 9.84% | 13.89% |